Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 Monotherapy in Advanced Solid Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is an open-label, single-arm, dose-escalation, and dose-expansion clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of ABO2011 monotherapy in patients with advanced solid tumors who have progressed or metastasized after systemic standard of treatment.
Epistemonikos ID: 0a9b77067a362dbe2e2d1eb0552e3b08e27c1162
First added on: May 15, 2024